Former FDA ODE II Director Meyer Building New Regulatory Sciences Center at UVA
This article was originally published in RPM Report
Executive Summary
Bob Meyer, a veteran of both sides of the FDA drug regulatory process from top-level positions in FDA’s drug review office and the Merck regulatory strategy and policy group, is trying to create a new regulatory science center at the University of Virginia that could add to FDA’s close-by academic support resources.